![]() |
市场调查报告书
商品编码
2021509
个人化营养保健品混合市场预测至2034年-按产品类型、成分、原料、订阅模式、应用、最终用户和地区分類的全球分析Personalized Nutraceutical Blends Market Forecasts to 2034 - Global Analysis By Product Type, Component, Raw Material, Subscription Model, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的数据,全球个人化营养保健品混合物市场预计将在 2026 年达到 84 亿美元,并在预测期内以 13.2% 的复合年增长率增长,到 2034 年达到 226 亿美元。
个人化营养保健品是指根据个别健康评估结果(包括基因检测、生物标记分析、饮食调查和人工智慧健康演算法)量身定制的配方,其中包含维生素、矿物质、植物萃取物、益生菌、蛋白质和功能性生物活性化合物。其目的是解决不同年龄层和生活方式人群的特定营养缺乏问题、实现健康目标并改善健康状况。
基于DNA的营养需求
对基于DNA的营养产品的需求正在加速个人化营养保健品的普及。这是因为价格亲民的D2C(直接面向消费者)基因检测使消费者能够在分子层面上识别营养代谢变异、营养缺乏倾向和补充剂需求。将基因组数据与人工智慧驱动的配方引擎相结合的公司正在吸引那些愿意为经过科学检验的个人化补充剂方案支付更高价格的健康意识消费者,从而推动D2C订阅平台的收入成长。
高昂的配方成本
高昂的配方和生产成本限制了个人化营养保健品在价格敏感型消费者中的市场渗透率。这是因为客製化生产需要专门的原材料采购、小批量生产设施和先进的品管系统,与大规模生产的保健品相比,这些都会显着增加单位成本。高昂的价格使得个人化营养保健品超出了全球大多数潜在消费者的负担范围。
融入企业健康体系
将产品整合到企业健康计画中蕴藏着大规模的分销机会。这是因为雇主赞助的健康计画越来越多地将个人化营养补充品纳入其中,以降低医疗成本、提高员工生产力并改善员工健康。与企业健康管理机构签订的多员工合同,使订阅平台提供者能够获得大规模的经常性收入,同时透过与企业管道的伙伴关係降低单一客户的获客成本。
监理合规风险
监管合规的复杂性威胁着个人化膳食补充剂混合市场的成长。国际膳食补充剂法规繁多,涵盖健康益处声明、新成分核准和定製配方标准等各个方面,这些法规不仅构成市场准入壁垒,也带来了沉重的合规成本。随着美国食品药物管理局 (FDA) 和欧洲食品安全局 (EFSA) 对人工智慧产生的健康建议和个人化补充剂功效声明的监管力度不断加大,企业可能需要投入大量资金进行临床验证,这将使新兴平台营运商处于不利地位。
新冠疫情加速了个人化营养保健品的普及,疫情期间人们对免疫力的关注度提高,刺激了消费者对用于维持免疫功能的标靶补充剂的需求。远距健康检查平台和远端保健的整合,也使得人们能够更方便地获得个人化营养服务。在后疫情时代,人们对健康问题的持续关注和对预防性保健的投入,从根本上提高了对循证个性化营养保健品的需求,其认知水平远超疫情初期。
在预测期内,ω-3 和必需脂肪酸混合物细分市场预计将成为最大的细分市场。
预计在预测期内,Omega 和必需脂肪酸混合物细分市场将占据最大的市场份额。这主要归功于已确立的临床证据,这些证据支持Omega-3补充剂对心血管、认知功能和抗发炎等方面的健康益处,从而持续带动各年龄层消费者的高需求。医生经常推荐 Omega 补充剂,以及消费者因鱼贝类消费量下降而日益关注膳食中 EPA 和 DHA 的缺乏,共同促成了该细分市场在个性化混合产品类型中的主导地位。
预计在预测期内,硬体领域将呈现最高的复合年增长率。
在预测期内,硬体领域预计将呈现最高的成长率。这主要得益于家用生物标记检测设备、自动化营养补充剂分发系统以及可穿戴健康监测设备的日益普及,这些设备能够基于实时生理数据流,持续实现营养补充剂配方的个性化定制。硬体驱动的健康感测平台与人工智慧驱动的营养补充品推荐平台的融合,正在打造一个全新的高价值产品类型,预计将受到注重科技的健康消费者的青睐,并有望以溢价购买。
在预测期内,北美预计将占据最大的市场份额。这主要归功于美国拥有全球最成熟的D2C(直接面向消费者)营养补充品产业,消费者愿意为个人化健康产品支付高价,基因组检测的普及率不断提高,以及人工智慧营养平台开发商的主导地位。高人均健康相关自由裁量权支出、强大的数位健康基础设施以及有利于营养补充剂创新的法规环境,都为北美在个人化营养保健品领域的销售领先地位提供了有力支撑。
在预测期内,亚太地区预计将呈现最高的复合年增长率。这主要归功于中国、印度、日本和韩国健康意识日益增强的中产阶级人口的快速增长,以及他们对个性化健康习惯的采纳、保健品电商渠道的拓展,以及当地对营养基因组学研发和个性化营养平台建设的投入不断增加。政府推行的健康促进项目,包括支持预防性营养和扩大远端医疗基础设施,使得该地区的消费者更容易获得个人化营养保健品订阅服务。
主要进展
2026 年 3 月,Hims & Hers Health 宣布与一家基因组学公司建立策略合作伙伴关係,将基于 DNA 的营养代谢分析整合到其个人化健康和营养保健品订阅服务中。
2026 年 2 月,Viome Life Sciences 将其基于肠道微生物组的精准营养服务扩展到欧洲市场,透过其专有的 RNA定序技术,能够推荐个人化的益生菌和益生元混合物。
2026 年 1 月,Thorne Research推出了一款由人工智慧驱动的个人化补充剂平台,该平台将生物标誌物血液测试与客製化的每月营养保健品包处方相结合,并开始向 D2C(直接面向消费者)健康订阅用户提供该平台。
According to Stratistics MRC, the Global Personalized Nutraceutical Blends Market is accounted for $8.4 billion in 2026 and is expected to reach $22.6 billion by 2034 growing at a CAGR of 13.2% during the forecast period. Personalized nutraceutical blends refer to customized formulations of vitamins, minerals, botanical extracts, probiotics, proteins, and functional bioactive compounds assembled according to individualized health assessments derived from genetic testing, biomarker analysis, dietary surveys, and AI-driven health algorithms to address specific nutritional gaps, health goals, and wellness conditions of individual consumers across diverse age groups and lifestyle profiles.
DNA-Based Nutrition Demand
DNA-based nutrition demand is accelerating personalized nutraceutical blend adoption as affordable direct-to-consumer genetic testing enables consumers to identify nutrient metabolism variants, deficiency predispositions, and supplementation needs at the molecular level. Companies integrating genomic data with AI-driven formulation engines are attracting health-conscious consumers willing to pay premium prices for scientifically validated personalized supplement protocols, driving revenue expansion across direct-to-consumer subscription platforms.
High Formulation Costs
High formulation and manufacturing costs constrain personalized nutraceutical blend market penetration among price-sensitive consumer segments as customized production requires specialized ingredient sourcing, small-batch manufacturing infrastructure, and sophisticated quality control systems that substantially elevate per-unit production expenses relative to mass-market supplement alternatives. Premium pricing positions personalized blends beyond affordability thresholds for large portions of the potential global consumer population.
Corporate Wellness Integration
Corporate wellness program integration represents a high-volume distribution opportunity as employer-sponsored health programs adopt personalized nutraceutical supplementation to reduce healthcare costs, improve employee productivity, and enhance workforce wellness outcomes. Multi-employee contract arrangements with corporate wellness administrators enable subscription platform operators to secure large recurring revenue pools while reducing individual customer acquisition costs through institutional channel partnerships.
Regulatory Compliance Risks
Regulatory compliance complexity threatens personalized nutraceutical blend market expansion as varying international supplement regulations governing health claims, novel ingredient approvals, and customized formulation standards create market entry barriers and compliance cost burdens. Evolving FDA and EFSA scrutiny of AI-generated health recommendations and personalized supplement claims may require extensive clinical substantiation investments that disadvantage emerging platform operators.
COVID-19 accelerated personalized nutraceutical adoption as pandemic-era immunity consciousness elevated consumer interest in targeted supplementation for immune resilience. Remote health assessment platforms and telehealth integrations expanded digital access to personalized nutrition services. Post-pandemic sustained health engagement and preventive wellness investment have structurally elevated demand for science-backed personalized nutraceutical formulations beyond initial pandemic-driven awareness levels.
The omega & essential fatty acid blends segment is expected to be the largest during the forecast period
The omega & essential fatty acid blends segment is expected to account for the largest market share during the forecast period, due to well-established clinical evidence supporting omega-3 supplementation for cardiovascular, cognitive, and anti-inflammatory health benefits that drives consistent high-volume consumer demand across all demographic segments. Physician recommendation frequency for omega supplementation combined with growing consumer awareness of dietary EPA and DHA deficiencies from declining seafood consumption sustains this segment's dominant market position among personalized blend product categories.
The hardware segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hardware segment is predicted to witness the highest growth rate, driven by expanding deployment of at-home biomarker testing devices, automated nutraceutical dispensing systems, and wearable health monitoring equipment that enable continuous personalization of supplement formulations based on real-time physiological data streams. Integration of hardware-enabled health sensing with AI-driven supplement recommendation platforms is creating new high-value product categories that command premium pricing from technology-oriented wellness consumers.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's most mature direct-to-consumer supplement industry with established consumer willingness to pay premium prices for personalized health products, strong genomic testing adoption, and leading AI nutrition platform developers. High household discretionary health spending, robust digital health infrastructure, and favorable regulatory environments for dietary supplement innovation sustain North American revenue leadership across personalized nutraceutical categories.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly growing health-conscious middle-class populations in China, India, Japan, and South Korea adopting personalized wellness practices, expanding e-commerce supplement distribution, and increasing local investment in nutrigenomics research and personalized nutrition platform development. Government health promotion programs supporting preventive nutrition and growing telehealth infrastructure are accelerating regional consumer access to personalized nutraceutical subscription services.
Key players in the market
Some of the key players in Personalized Nutraceutical Blends Market include Care/of (Ritual), Persona Nutrition, Rootine, Baze, Nourished, Hims & Hers Health, Thorne Research, Metagenics, USANA Health Sciences, Amway (Nutrilite), Herbalife Nutrition, Nature's Sunshine Products, Gaia Herbs, New Chapter, Garden of Life, Pure Encapsulations, and Viome Life Sciences.
Key Developments
In March 2026, Hims & Hers Health announced a strategic partnership with a genomics company to integrate DNA-based nutrient metabolism profiling into its personalized wellness and nutraceutical subscription offerings.
In February 2026, Viome Life Sciences expanded its gut microbiome-based precision nutrition service to European markets, enabling personalized probiotic and prebiotic blend recommendations through proprietary RNA sequencing technology
In January 2026, Thorne Research launched an AI-powered personalized supplement platform integrating biomarker blood testing with customized monthly nutraceutical pack formulation for direct-to-consumer wellness subscribers.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.